4.5 Letter

Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases

Journal

BONE MARROW TRANSPLANTATION
Volume 58, Issue 3, Pages 340-342

Publisher

SPRINGERNATURE
DOI: 10.1038/s41409-022-01894-1

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available